Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Wolff

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Bone Marrow Transplantation|August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationD J Winston, J H Antin, S N Wolff, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Bone Marrow Transplantation|August 18, 2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationD J Winston, J H Antin, S N Wolff, et al.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Pageof 10